Scalper1 News
Medical-device giant Boston Scientific (BSX) was down sharply Wednesday after the U.S. government proposed limiting coverage of its new heart implant. Late Tuesday, the Center for Medicare and Medicaid Service (CMS) issued the proposed guidelines covering the use of percutaneous left atrial appendage closure therapy, which is the purpose of Boston Scientific’s Watchman device. The memo concluded that “the evidence is sufficient to determine Scalper1 News
Scalper1 News